Panel Discussion: Diversity, Equity, & Inclusion: How to Ensure Successful Enrollment of Under- Represented Communities in Oncology & Non-Oncology Indications
Time: 10:30 am
day: Conference Day Two - AM
Details:
- What impact is the reduction in available assays in Europe having on clinical trials?
- What does this mean for patient representation?
- How are all stakeholders involved in promoting diversity, equity, and inclusion in the co-development of CDx and drugs for more patients?
Speakers:
